Modulatory effects of hypocretin-1/orexin-A with glutamate and γ-aminobutyric acid on freshly isolated pyramidal neurons from the rat prefrontal cortex

Neuroscience Letters

Volumn 399, Issue 1-2, 2006, Pages 101-105

  Song, Cheng hui ^a   Chen, Xiao wei ^a   Xia, Jian xia ^a   Yu, Zheng ping ^a   Hu, Zhi an ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Aminobutyric acid; Glutamate; Hypocretins; Prefrontal cortex; Pyramidal neurons; Wakefulness

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; OREXIN A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC SYSTEM; NERVE CELL EXCITABILITY; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PATCH CLAMP; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PYRAMIDAL NERVE CELL; RAT; RECEPTOR INTRINSIC ACTIVITY; WHOLE CELL;

ACTION POTENTIALS; ANIMALS; FRONTAL LOBE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; RATS; RATS, WISTAR;

EID: 33646077902     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.01.065     Document Type: Article

References (37)

1. Bayer L., Serafin M., Eggermann E., Saint-Mleux B., Machard D., Jones B.E., and Muhlethaler M. Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons. J. Neurosci. 24 (2004) 6760-6764
2. Boutrel B., and Koob G.F. What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep 27 (2004) 1181-1194
3. Bowery N.G., Hudson A.L., and Price G.W. GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience 20 (1987) 365-383
4. Cai X., Flores-Hernandez J., Feng J., and Yan Z. Activity-dependent bidirectional regulation of GABA(A) receptor channels by the 5-HT(4) receptor-mediated signalling in rat prefrontal cortical pyramidal neurons. J. Physiol. 540 (2002) 743-759
5. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., and Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98 (1999) 437-451
6. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., and Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 322-327
7. Feenstra M.G., Botterblom M.H., and van Uum J.F. Behavioral arousal and increased dopamine efflux after blockade of NMDA-receptors in the prefrontal cortex are dependent on activation of glutamatergic neurotransmission. Neuropharmacology 42 (2002) 752-763
8. Feng J., Cai X., Zhao J., and Yan Z. Serotonin receptors modulate GABA(A) receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons. J. Neurosci. 21 17 (2001) 6502-6511
9. Goldman-Rakic P.S. Cellular basis of working memory. Neuron 14 (1995) 477-485
10. Lambe E.K., and Aghajanian G.K. Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron 40 (2003) 139-150
11. Lewis D.A., Volk D.W., and Hashimoto T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl.) 174 (2004) 143-150
12. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P.J., Nishino S., and Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98 (1999) 365-376
13. Lu X.Y., Bagnol D., Burke S., Akil H., and Watson S.J. Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm. Behav. 37 (2000) 335-344
14. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., and Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435 (2001) 6-25
15. Martin G., Fabre V., Siggins G.R., and de Lecea L. Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regul. Pept. 104 (2002) 111-117
16. Maurice N., Tkatch T., Meisler M., Sprunger L.K., and Surmeier D.J. D1/D5 dopamine receptor activation differentially modulates rapidly inactivating and persistent sodium currents in prefrontal cortex pyramidal neurons. J. Neurosci. 21 (2001) 2268-2277
17. Miller E.K. The prefrontal cortex and cognitive control. Nat. Rev. Neurosci. 1 (2000) 59-65
18. Moghaddam B., Adams B., Verma A., and Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 17 (1997) 2921-2927
19. Muly E.C., Maddox M., and Smith Y. Distribution of mGluR1alpha and mGluR5 immunolabeling in primate prefrontal cortex. J. Comp. Neurol. 467 (2003) 521-535
20. Naumann A., Bierbrauer J., Przuntek H., and Daum I. Attentive and preattentive processing in narcolepsy as revealed by event-related potentials (ERPs). Neuroreport 12 (2001) 2807-2811
21. Paus T., Koski L., Caramanos Z., and Westbury C. Regional differences in the effects of task difficulty and motor output on blood flow response in the human anterior cingulate cortex: a review of 107 PET activation studies. Neuroreport 9 (1998) R37-R47
22. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., and Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18 (1998) 9996-10015
23. Rieger M., Mayer G., and Gauggel S. Attention deficits in patients with narcolepsy. Sleep 26 (2003) 36-43
24. Rudolf G.D., Cronin C.A., Landwehrmeyer G.B., Standaert D.G., Penney Jr. J.B., and Young A.B. Expression of N-methyl-d-aspartate glutamate receptor subunits in the prefrontal cortex of the rat. Neuroscience 73 (1996) 417-427
25. Sakurai T., memiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., and Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92 (1998) 573-585
26. Song C.H., Xia J.X., Ye J.N., Chen X.W., Zhang C.Q., Gao E.Q., and Hu Z.A. Signaling pathways of hypocretin-1 actions on pyramidal neurons in the rat prefrontal cortex. Neuroreport 16 (2005) 1529-1533
27. Sutcliffe J.G., and de Lecea L. The hypocretins: setting the arousal threshold. Nat. Rev. Neurosci. 3 (2002) 339-349
28. Thomas M., Sing H., Belenky G., Holcomb H., Mayberg H., Dannals R., Wagner H., Thorne D., Popp K., Rowland L., Welsh A., Balwinski S., and Redmond D. Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. J. Sleep Res. 9 (2000) 335-352
29. Tseng K.Y., and O'Donnell P. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J. Neurosci. 24 (2004) 5131-5139
30. Wang X.J. Synaptic basis of cortical persistent activity: the importance of NMDA receptors to working memory. J. Neurosci. 19 (1999) 9587-9603
31. Wang J., and O'Donnell P. D(1) dopamine receptors potentiate nmda-mediated excitability increase in layer V prefrontal cortical pyramidal neurons. Cereb. Cortex 11 (2001) 452-462
32. Willie J.T., Chemelli R.M., Sinton C.M., Tokita S., Williams S.C., Kisanuki Y.Y., Marcus J.N., Lee C., Elmquist J.K., Kohlmeier K.A., Leonard C.S., Richardson J.A., Hammer R.E., and Yanagisawa M. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 38 (2003) 715-730
33. Wirkner K., Krause T., Koles L., Thummler S., Al-Khrasani M., and Illes P. D1 but not D2 dopamine receptors or adrenoceptors mediate dopamine-induced potentiation of N-methyl-d-aspartate currents in the rat prefrontal cortex. Neurosci. Lett. 372 (2004) 89-93
34. Xia J., Chen X., Song C., Ye J., Yu Z., and Hu Z. Postsynaptic excitation of prefrontal cortical pyramidal neurons by hypocretin-1/orexin a through the inhibition of potassium currents. J. Neurosci. Res. 82 (2005) 729-736
35. Yamasaki H., LaBar K.S., and McCarthy G. Dissociable prefrontal brain systems for attention and emotion. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 11447-11451
36. Yuen E.Y., Jiang Q., Chen P., Gu Z., Feng J., and Yan Z. Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism. J. Neurosci. 25 (2005) 5488-5501
37. Zhong P., Gu Z., Wang X., Jiang H., Feng J., and Yan Z. Impaired modulation of GABAergic transmission by muscarinic receptors in a mouse transgenic model of Alzheimer's disease. J. Biol. Chem. 278 (2003) 26888-26896